Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease
Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endo...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 46; no. 2; pp. 175 - 182 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.07.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0269-2813 1365-2036 1365-2036 |
DOI | 10.1111/apt.14119 |
Cover
Loading…
Abstract | Summary
Background
Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.
Aim
To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.
Methods
The endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.
Results
A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.
Conclusions
Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.
Linked ContentThis article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154. |
---|---|
AbstractList | Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.
To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.
The endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.
A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.
Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. BackgroundPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.AimTo test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.MethodsThe endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.ResultsA total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.ConclusionsEndotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia. Methods The endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity. Results A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level. Conclusions Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. Linked ContentThis article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154. Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.BACKGROUNDPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.AIMTo test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.The endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.METHODSThe endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.RESULTSA total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.CONCLUSIONSEndotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. Linked Content This article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154 . |
Author | Yu, J. Choi, P. C.‐L. Xu, W. Chan, A. W.‐H. Chan, H.‐Y. Tse, C.‐H. Wong, V. W.‐S. Zhang, X. Pang, J. Shu, S. S.‐T. Chan, H. L.‐Y. Wong, G. L.‐H. |
Author_xml | – sequence: 1 givenname: J. surname: Pang fullname: Pang, J. organization: The Chinese University of Hong Kong – sequence: 2 givenname: W. surname: Xu fullname: Xu, W. organization: The Chinese University of Hong Kong – sequence: 3 givenname: X. surname: Zhang fullname: Zhang, X. organization: The Chinese University of Hong Kong – sequence: 4 givenname: G. L.‐H. orcidid: 0000-0002-2863-9389 surname: Wong fullname: Wong, G. L.‐H. organization: The Chinese University of Hong Kong – sequence: 5 givenname: A. W.‐H. surname: Chan fullname: Chan, A. W.‐H. organization: The Chinese University of Hong Kong – sequence: 6 givenname: H.‐Y. surname: Chan fullname: Chan, H.‐Y. organization: The Chinese University of Hong Kong – sequence: 7 givenname: C.‐H. surname: Tse fullname: Tse, C.‐H. organization: The Chinese University of Hong Kong – sequence: 8 givenname: S. S.‐T. surname: Shu fullname: Shu, S. S.‐T. organization: The Chinese University of Hong Kong – sequence: 9 givenname: P. C.‐L. surname: Choi fullname: Choi, P. C.‐L. organization: The Chinese University of Hong Kong – sequence: 10 givenname: H. L.‐Y. surname: Chan fullname: Chan, H. L.‐Y. organization: The Chinese University of Hong Kong – sequence: 11 givenname: J. surname: Yu fullname: Yu, J. email: junyu@cuhk.edu.hk organization: The Chinese University of Hong Kong – sequence: 12 givenname: V. W.‐S. orcidid: 0000-0003-2215-9410 surname: Wong fullname: Wong, V. W.‐S. email: wongv@cuhk.edu.hk organization: The Chinese University of Hong Kong |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28464257$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctuFDEQRS0URCaBBT-ALLGBRSd-tbt7GUW8pEggEdaW21OdqchjN7YnyeyQ-AG-kS_BZCabCLypzTnXpbpH5CDEAIS85OyE13dq53LCFefDE7LgUreNYFIfkAUTemhEz-UhOcr5mjGmOyaekUPRK61E2y3Iz694FXBCZ0Ohc8xY8AaozTk6tAVjoHGiEJaxxDtYo6W3WFZ0hblEH6-q5mmGG0hYthQDFbKjc_UglLxD66q_f_yy3sVV9OjoZEtFff0l0SVmsBmek6eT9Rle7Ocx-fb-3eX5x-bi84dP52cXjZN9PzSOy1GDsy1XfSdB8b5Oq0F2amy5nqQcB-gUB-E6oUDJltvROjEoJkBOnTwmb3a5c4rfN5CLWWN24L0NEDfZ8H5QA--l1hV9_Qi9jpsU6naGD0IopXjHKvVqT23GNSzNnHBt09Y8nLcCpzvApZhzgsk4LPdnLcmiN5yZvwWaWqC5L7Aabx8ZD6H_Yvfpt-hh-3_QnH253Bl_AEj1q-Y |
CitedBy_id | crossref_primary_10_1007_s11892_020_01342_8 crossref_primary_10_1155_2019_8507583 crossref_primary_10_3389_fendo_2020_613639 crossref_primary_10_1038_s41598_019_45009_1 crossref_primary_10_1055_s_0041_1723752 crossref_primary_10_1088_1755_1315_1371_6_062022 crossref_primary_10_1128_spectrum_05230_22 crossref_primary_10_1007_s12072_020_10081_7 crossref_primary_10_1016_j_phanu_2020_100213 crossref_primary_10_1038_s41575_021_00472_y crossref_primary_10_1016_j_jacbts_2023_07_003 crossref_primary_10_1038_s41591_022_01850_y crossref_primary_10_1002_jev2_12303 crossref_primary_10_1016_j_smim_2023_101859 crossref_primary_10_1002_hep_30908 crossref_primary_10_1111_ijpo_13091 crossref_primary_10_1177_20420188241242937 crossref_primary_10_1111_dom_15014 crossref_primary_10_1111_1751_2980_12845 crossref_primary_10_3390_ijms221910470 crossref_primary_10_1007_s12275_022_2087_y crossref_primary_10_1038_s41575_018_0009_6 crossref_primary_10_3390_nu11081712 crossref_primary_10_1016_j_jcmgh_2023_09_002 crossref_primary_10_1111_jam_14992 crossref_primary_10_1038_s41577_019_0198_4 crossref_primary_10_1038_s42255_024_01156_y crossref_primary_10_1016_j_joim_2021_07_004 crossref_primary_10_3390_ijms21041525 crossref_primary_10_1111_eci_14224 crossref_primary_10_1016_j_trsl_2020_11_003 crossref_primary_10_1016_j_lfs_2023_121614 crossref_primary_10_1016_j_jhepr_2019_09_001 crossref_primary_10_3390_microorganisms8111744 crossref_primary_10_1002_kjm2_12904 crossref_primary_10_1111_liv_14571 crossref_primary_10_1016_j_omtn_2022_08_003 crossref_primary_10_1111_apt_14154 crossref_primary_10_3390_cells9010037 crossref_primary_10_1097_MPG_0000000000002111 crossref_primary_10_1371_journal_pmed_1002894 crossref_primary_10_1016_j_bbrc_2020_08_036 crossref_primary_10_1016_j_cmet_2024_05_008 crossref_primary_10_3390_cancers15010023 crossref_primary_10_25040_lkv2022_03_04_008 crossref_primary_10_3390_diseases7010027 crossref_primary_10_1038_ijo_2017_162 crossref_primary_10_3389_fendo_2023_1196831 crossref_primary_10_1007_s12072_021_10286_4 crossref_primary_10_1111_1751_2980_12709 crossref_primary_10_31146_1682_8658_ecg_185_1_4_52 crossref_primary_10_1111_jgh_15729 crossref_primary_10_1016_j_jksus_2020_03_019 crossref_primary_10_3390_nu14245261 crossref_primary_10_1016_j_tem_2022_01_002 crossref_primary_10_1097_QAD_0000000000002133 crossref_primary_10_5694_mja17_01067 crossref_primary_10_1038_s42255_024_01177_7 crossref_primary_10_1002_hep_31056 crossref_primary_10_3390_nu10111793 |
Cites_doi | 10.1038/nature11053 10.1136/gutjnl-2015-309265 10.1016/S1665-2681(19)31364-X 10.1053/j.gastro.2016.01.005 10.1111/apt.12569 10.1073/pnas.1323785111 10.1126/science.1208344 10.1002/hep.23312 10.1073/pnas.0407076101 10.1111/j.1572-0241.2001.03702.x 10.1074/jbc.M116.719955 10.1111/apt.13327 10.1016/j.jhep.2011.12.025 10.1007/s11695-007-9243-7 10.1002/hep.28142 10.1002/hep.27556 10.1002/hep.25762 10.1111/apt.12609 10.1038/76048 10.1186/1476-9255-7-15 10.1038/ng.257 10.1136/gut.2009.205088 10.1016/j.cgh.2014.04.014 10.1002/hep.28475 10.1002/hep.26299 10.1371/journal.pgen.1001324 10.1111/apt.13833 10.1016/j.jhep.2014.04.047 10.2337/db09-0367 10.1038/ng.2901 10.1002/hep.26093 10.1002/hep.28572 10.2337/db07-1403 10.1002/hep.28356 10.1002/hep.20701 10.1002/hep.22848 10.1053/j.gastro.2012.01.034 10.1016/j.jhep.2008.05.025 10.1002/hep.27490 10.1002/hep.28697 10.1111/apt.13232 10.1111/j.1462-5822.2006.00796.x 10.1007/s00125-007-0791-0 10.1053/j.gastro.2010.11.049 10.1016/0168-8278(91)90933-3 10.1038/ng.2926 10.3748/wjg.v19.i40.6911 10.1371/journal.pone.0062885 10.1038/nature13398 |
ContentType | Journal Article |
Copyright | 2017 John Wiley & Sons Ltd 2017 John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2017 John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 H94 K9. M7N 7X8 |
DOI | 10.1111/apt.14119 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Neurosciences Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2036 |
EndPage | 182 |
ExternalDocumentID | 28464257 10_1111_apt_14119 APT14119 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Food and Health Bureau of the Hong Kong SAR Government funderid: 11120621 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DTERQ E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA GX1 H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TR2 TUS UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YOC ZZTAW ~IA ~WT AAYXX AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. M7N 7X8 |
ID | FETCH-LOGICAL-c3889-c13b6eca514873e418487a6e374b516f33b9e741e2c724e4351abac29402e3f73 |
IEDL.DBID | DR2 |
ISSN | 0269-2813 1365-2036 |
IngestDate | Fri Jul 11 06:52:06 EDT 2025 Fri Jul 25 10:09:13 EDT 2025 Wed Feb 19 02:43:51 EST 2025 Tue Jul 01 02:22:19 EDT 2025 Thu Apr 24 23:04:53 EDT 2025 Wed Jan 22 16:42:45 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3889-c13b6eca514873e418487a6e374b516f33b9e741e2c724e4351abac29402e3f73 |
Notes | Linked Content The Handling Editor for this article was Professor Stephen Harrison, and it was accepted for publication after full peer‐review. . This article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2215-9410 0000-0002-2863-9389 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14119 |
PMID | 28464257 |
PQID | 1922444170 |
PQPubID | 2045200 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1894918366 proquest_journals_1922444170 pubmed_primary_28464257 crossref_citationtrail_10_1111_apt_14119 crossref_primary_10_1111_apt_14119 wiley_primary_10_1111_apt_14119_APT14119 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2017 2017-07-00 2017-Jul 20170701 |
PublicationDateYYYYMMDD | 2017-07-01 |
PublicationDate_xml | – month: 07 year: 2017 text: July 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester |
PublicationTitle | Alimentary pharmacology & therapeutics |
PublicationTitleAlternate | Aliment Pharmacol Ther |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2015; 13 2007; 17 2004; 101 2014; 514 2011; 334 2012; 142 2010; 59 2012; 486 1991; 12 2000; 25 2017; 65 2005; 41 2008; 57 2014; 46 2007; 50 2013; 8 2014; 111 2012; 56 2014; 61 2012; 55 2009; 49 2011; 7 2013; 19 2013; 57 2015; 62 2013; 12 2015; 61 2015; 42 2008; 49 2016; 65 2016; 64 2016; 63 2008; 21 2014; 39 2011; 140 2008; 40 2016; 291 2010; 7 2010; 51 2001; 96 1998; 282 2016; 150 2016; 44 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 Kohjima M (e_1_2_7_33_1) 2008; 21 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_23_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_37_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 28677287 - Aliment Pharmacol Ther. 2017 Aug;46(3):377-378 |
References_xml | – volume: 63 start-page: 764 year: 2016 end-page: 775 article-title: The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota publication-title: Hepatology – volume: 41 start-page: 1313 year: 2005 end-page: 1321 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: Hepatology – volume: 56 start-page: 1363 year: 2012 end-page: 1370 article-title: Non‐invasive diagnosis of non‐alcoholic steatohepatitis by combined serum biomarkers publication-title: J Hepatol – volume: 12 start-page: 162 year: 1991 end-page: 169 article-title: Plasma endotoxin concentrations in patients with alcoholic and non‐alcoholic liver disease: reevaluation with an improved chromogenic assay publication-title: J Hepatol – volume: 39 start-page: 254 year: 2014 end-page: 269 article-title: Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin‐18 fragments publication-title: Aliment Pharmacol Ther – volume: 25 start-page: 187 year: 2000 end-page: 191 article-title: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans publication-title: Nat Genet – volume: 334 start-page: 105 year: 2011 end-page: 108 article-title: Linking long‐term dietary patterns with gut microbial enterotypes publication-title: Science – volume: 514 start-page: 508 year: 2014 end-page: 512 article-title: High‐fat‐diet‐mediated dysbiosis promotes intestinal carcinogenesis independently of obesity publication-title: Nature – volume: 8 start-page: e62885 year: 2013 article-title: Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis–a longitudinal study publication-title: PLoS ONE – volume: 57 start-page: 1470 year: 2008 end-page: 1481 article-title: Changes in gut microbiota control metabolic endotoxemia‐induced inflammation in high‐fat diet‐induced obesity and diabetes in mice publication-title: Diabetes – volume: 96 start-page: 1200 year: 2001 end-page: 1204 article-title: Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis publication-title: Am J Gastroenterol – volume: 7 start-page: 15 year: 2010 article-title: Elevated endotoxin levels in non‐alcoholic fatty liver disease publication-title: J Inflamm (Lond) – volume: 42 start-page: 99 year: 2015 end-page: 105 article-title: Patatin‐like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages publication-title: Aliment Pharmacol Ther – volume: 65 start-page: 451 year: 2017 end-page: 464 article-title: Gut microbiota profiling of pediatric NAFLD and obese patients unveiled by an integrated meta‐omics based approach publication-title: Hepatology – volume: 39 start-page: 532 year: 2014 end-page: 539 article-title: PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome publication-title: Aliment Pharmacol Ther – volume: 40 start-page: 1461 year: 2008 end-page: 1465 article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease publication-title: Nat Genet – volume: 21 start-page: 507 year: 2008 end-page: 511 article-title: SREBP‐1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease publication-title: Int J Mol Med – volume: 61 start-page: 515 year: 2015 end-page: 525 article-title: Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity publication-title: Hepatology – volume: 51 start-page: 454 year: 2010 end-page: 462 article-title: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 49 start-page: 1877 year: 2009 end-page: 1887 article-title: Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 111 start-page: 8913 year: 2014 end-page: 8918 article-title: TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content publication-title: Proc Natl Acad Sci USA – volume: 61 start-page: 708 year: 2014 end-page: 709 article-title: Prevalence of the TM6SF2 variant and non‐alcoholic fatty liver disease in Chinese publication-title: J Hepatol – volume: 291 start-page: 10659 year: 2016 end-page: 10676 article-title: Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins publication-title: J Biol Chem – volume: 7 start-page: e1001324 year: 2011 article-title: Genome‐wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits publication-title: PLoS Genet – volume: 13 start-page: 643 year: 2015 end-page: 654 article-title: Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta‐analysis of paired‐biopsy studies publication-title: Clin Gastroenterol Hepatol – volume: 150 start-page: 1208 year: 2016 end-page: 1218 article-title: Hepatic transmembrane 6 superfamily member 2 regulates cholesterol metabolism in mice publication-title: Gastroenterology – volume: 65 start-page: 54 year: 2017 end-page: 64 article-title: Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients publication-title: Hepatology – volume: 59 start-page: 969 year: 2010 end-page: 974 article-title: Disease progression of non‐alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years publication-title: Gut – volume: 65 start-page: 1359 year: 2016 end-page: 1368 article-title: Screening diabetic patients for non‐alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study publication-title: Gut – volume: 19 start-page: 6911 year: 2013 end-page: 6918 article-title: Effects of probiotics on nonalcoholic fatty liver disease: a meta‐analysis publication-title: World J Gastroenterol – volume: 61 start-page: 506 year: 2015 end-page: 514 article-title: Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease publication-title: Hepatology – volume: 142 start-page: 1100 year: 2012 end-page: 1101 article-title: A high‐fat diet is associated with endotoxemia that originates from the gut publication-title: Gastroenterology – volume: 140 start-page: 976 year: 2011 end-page: 986 article-title: Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency publication-title: Gastroenterology – volume: 101 start-page: 15718 year: 2004 end-page: 15723 article-title: The gut microbiota as an environmental factor that regulates fat storage publication-title: Proc Natl Acad Sci USA – volume: 49 start-page: 821 year: 2008 end-page: 830 article-title: Probiotics improve high fat diet‐induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells publication-title: J Hepatol – volume: 50 start-page: 2374 year: 2007 end-page: 2383 article-title: Selective increases of bifidobacteria in gut microflora improve high‐fat‐diet‐induced diabetes in mice through a mechanism associated with endotoxaemia publication-title: Diabetologia – volume: 42 start-page: 731 year: 2015 end-page: 740 article-title: Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study publication-title: Aliment Pharmacol Ther – volume: 46 start-page: 352 year: 2014 end-page: 356 article-title: Exome‐wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease publication-title: Nat Genet – volume: 282 start-page: 2085 year: 1998 end-page: 2088 article-title: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene publication-title: Science – volume: 46 start-page: 345 year: 2014 end-page: 351 article-title: Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk publication-title: Nat Genet – volume: 62 start-page: 1742 year: 2015 end-page: 1756 article-title: The dual and opposite role of the TM6SF2‐rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta‐analysis publication-title: Hepatology – volume: 44 start-page: 1168 year: 2016 end-page: 1182 article-title: Review article: novel methods for the treatment of non‐alcoholic steatohepatitis ‐ targeting the gut immune system to decrease the systemic inflammatory response without immune suppression publication-title: Aliment Pharmacol Ther – volume: 55 start-page: 2005 year: 2012 end-page: 2023 article-title: The diagnosis and management of non‐alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association publication-title: Hepatology – volume: 12 start-page: 256 year: 2013 end-page: 262 article-title: Treatment of nonalcoholic steatohepatitis with probiotics. A proof‐of‐concept study publication-title: Ann Hepatol – volume: 486 start-page: 222 year: 2012 end-page: 227 article-title: Human gut microbiome viewed across age and geography publication-title: Nature – volume: 57 start-page: 2525 year: 2013 end-page: 2531 article-title: Dietary fructose in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 64 start-page: 34 year: 2016 end-page: 46 article-title: Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes publication-title: Hepatology – volume: 57 start-page: 601 year: 2013 end-page: 609 article-title: Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH publication-title: Hepatology – volume: 59 start-page: 172 year: 2010 end-page: 181 article-title: Experimental endotoxemia induces adipose inflammation and insulin resistance in humans publication-title: Diabetes – volume: 17 start-page: 1374 year: 2007 end-page: 1380 article-title: Lipopolysaccharide‐binding protein plasma levels and liver TNF‐alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non‐alcoholic steatohepatitis publication-title: Obes Surg – ident: e_1_2_7_51_1 doi: 10.1038/nature11053 – ident: e_1_2_7_2_1 doi: 10.1136/gutjnl-2015-309265 – ident: e_1_2_7_35_1 doi: 10.1016/S1665-2681(19)31364-X – ident: e_1_2_7_23_1 doi: 10.1053/j.gastro.2016.01.005 – ident: e_1_2_7_25_1 doi: 10.1111/apt.12569 – ident: e_1_2_7_21_1 doi: 10.1073/pnas.1323785111 – ident: e_1_2_7_48_1 doi: 10.1126/science.1208344 – ident: e_1_2_7_28_1 doi: 10.1002/hep.23312 – ident: e_1_2_7_32_1 doi: 10.1073/pnas.0407076101 – ident: e_1_2_7_31_1 doi: 10.1111/j.1572-0241.2001.03702.x – ident: e_1_2_7_47_1 doi: 10.1074/jbc.M116.719955 – ident: e_1_2_7_16_1 doi: 10.1111/apt.13327 – ident: e_1_2_7_29_1 doi: 10.1016/j.jhep.2011.12.025 – ident: e_1_2_7_6_1 doi: 10.1007/s11695-007-9243-7 – ident: e_1_2_7_45_1 doi: 10.1002/hep.28142 – ident: e_1_2_7_44_1 doi: 10.1002/hep.27556 – ident: e_1_2_7_27_1 doi: 10.1002/hep.25762 – ident: e_1_2_7_19_1 doi: 10.1111/apt.12609 – ident: e_1_2_7_39_1 doi: 10.1038/76048 – ident: e_1_2_7_7_1 doi: 10.1186/1476-9255-7-15 – ident: e_1_2_7_18_1 doi: 10.1038/ng.257 – ident: e_1_2_7_4_1 doi: 10.1136/gut.2009.205088 – ident: e_1_2_7_3_1 doi: 10.1016/j.cgh.2014.04.014 – ident: e_1_2_7_46_1 doi: 10.1002/hep.28475 – ident: e_1_2_7_12_1 doi: 10.1002/hep.26299 – ident: e_1_2_7_5_1 doi: 10.1371/journal.pgen.1001324 – ident: e_1_2_7_37_1 doi: 10.1111/apt.13833 – ident: e_1_2_7_42_1 doi: 10.1016/j.jhep.2014.04.047 – ident: e_1_2_7_41_1 doi: 10.2337/db09-0367 – ident: e_1_2_7_17_1 doi: 10.1038/ng.2901 – volume: 21 start-page: 507 year: 2008 ident: e_1_2_7_33_1 article-title: SREBP‐1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease publication-title: Int J Mol Med – ident: e_1_2_7_9_1 doi: 10.1002/hep.26093 – ident: e_1_2_7_11_1 doi: 10.1002/hep.28572 – ident: e_1_2_7_13_1 doi: 10.2337/db07-1403 – ident: e_1_2_7_30_1 doi: 10.1002/hep.28356 – ident: e_1_2_7_26_1 doi: 10.1002/hep.20701 – ident: e_1_2_7_14_1 doi: 10.1002/hep.22848 – ident: e_1_2_7_50_1 doi: 10.1053/j.gastro.2012.01.034 – ident: e_1_2_7_34_1 doi: 10.1016/j.jhep.2008.05.025 – ident: e_1_2_7_43_1 doi: 10.1002/hep.27490 – ident: e_1_2_7_24_1 doi: 10.1002/hep.28697 – ident: e_1_2_7_20_1 doi: 10.1111/apt.13232 – ident: e_1_2_7_38_1 doi: 10.1111/j.1462-5822.2006.00796.x – ident: e_1_2_7_40_1 doi: 10.1007/s00125-007-0791-0 – ident: e_1_2_7_8_1 doi: 10.1053/j.gastro.2010.11.049 – ident: e_1_2_7_15_1 doi: 10.1016/0168-8278(91)90933-3 – ident: e_1_2_7_22_1 doi: 10.1038/ng.2926 – ident: e_1_2_7_36_1 doi: 10.3748/wjg.v19.i40.6911 – ident: e_1_2_7_10_1 doi: 10.1371/journal.pone.0062885 – ident: e_1_2_7_49_1 doi: 10.1038/nature13398 – reference: 28677287 - Aliment Pharmacol Ther. 2017 Aug;46(3):377-378 |
SSID | ssj0006702 |
Score | 2.4737291 |
Snippet | Summary
Background
Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.
Aim
To test the hypothesis that... Linked Content This article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154 . Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. To test the hypothesis that endotoxemia is associated... BackgroundPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.AimTo test the hypothesis that endotoxemia... Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.BACKGROUNDPatients with nonalcoholic steatohepatitis... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 175 |
SubjectTerms | Acute-Phase Proteins Adult Aged Alanine Alanine transaminase Alleles Aspartate aminotransferase Biomarkers Biopsy Body mass Body Mass Index Carrier Proteins - blood Cytokeratin Dysbacteriosis Endotoxemia Endotoxemia - epidemiology Fatty liver Female Fibrosis Hemoglobin Humans Intestine Intestines - microbiology Keratin-18 - blood Lipopolysaccharide-binding protein Liver - pathology Liver diseases Male Membrane Glycoproteins - blood Middle Aged Multivariate analysis Non-alcoholic Fatty Liver Disease - epidemiology Severity of Illness Index |
Title | Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.14119 https://www.ncbi.nlm.nih.gov/pubmed/28464257 https://www.proquest.com/docview/1922444170 https://www.proquest.com/docview/1894918366 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dT9swFLWqPiBeYDDYyjrkTTzwEkRix060JzSB2KZO0wCpD0iR7V1P0SCt1nRCPE3aH9hv5Jdw7TjhYyBNvFXKTZ3aPva58em5hGzt2lykNo8jm2RpxCW3UQbaVU01QuV41frSCaPP4vCEfxyn4x551_4XpvGH6F64OWT49doBXOnZLZCraY0wj73lp9NqOUL09cY6SkivN8QUI4-SLGbBVcipeLo77-5F_xDMu3zVbzgHy-S0fdRGZ_JjZ17rHXN5z8Xxib_lGVkKRJTuNTNnhfSgWiULo3DU_pz8OSq_V05HhF1PG2nXL6DqZjTpxFKoMKmdXMB5qah7o0u9fXFYTiluuuBq49GyogmTNHi4zprQalJd_f6rmhK9paFW1Rh65nQiNBwbrZGTg_3j94dRqNgQGebkUiZmWoBRyMIyyYBj-phJJYBJrtNYWMZ0DshhIDEy4YBULVZamSTHLBaYlWyd9LF1eEmo5THXgLekDEleylXK8at3gSFH-YbQHpDtduwKE-zMXVWNs6JNa7BTC9-pA_K2C502Hh4PBQ3bCVAEGM8KpL9If3gssbk33WUEoDtVURVM5hiT5TzHhVGIAXnRTJyuFdz7hVsU8WH98D_efLH35dh_2Pj_0FdkMXEkw4uHh6Rf_5zDa6RItd5ELHz4tOkRcQ1d8A6f |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9UwFD8hkAgvoAJ6FbQQH3gZYWvXbokvxECuwiUELwkvZOnKqbkRdonsGuOTiV_Az-gn8bTrxh8lIb4t6enatT2nv9Oe_Q7Amy2by9TmcWSTLI2EEjbKsHRZU43UOZVanzphcCD7x-LDSXoyBW_bf2EafojuwM1phrfXTsHdgfQNLdeXNel57Dg_Z1xGb-9QHV2TR0nlIw7JycijJIt54BVycTxd1du70V8Q8zZi9VvO7gKctp1tIk0-b07qctN8v8Pj-L9f8xjmAxZl283ieQJTWD2FR4Nw274IPz-OPlUulIhGnzXRXV-R6esJZWPLsCK_dvwNL0aauUNd5hmMg0VltO-iS4_HRhVLuGKBxvWqEa3G1e8fv3STpXdkmNU1iZ67UBEWbo6W4Hh3Z_iuH4WkDZHhLmLKxLyUaDQBsUxxFORBZkpL5EqUaSwt52WOBGMwMSoRSGgt1qU2SU6OLHKr-DJMU-v4HJgVsSiRqqSccF4qdCro1VvICaackXb3YKOdvMIERnOXWOO8aD0bGtTCD2oP1jvRy4bG419CK-0KKIImXxWEgAkBiVhRc2tdMemgu1jRFY4nJJPlIifbKGUPnjUrp2uFtn_p7CJ11s___c0X24dD__Di4aKvYbY_HOwX--8P9l7CXOIwh48lXoHp-ssEVwkx1eUrrxh_AM13EcE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4hKiEu9I_CAm3dikMvQZvYsRP1hKAr-gNCLUgckCLHjNGqkF1BFqGeKvUF-ox9EsaOEwotEuIWyePYsWfsb-zJNwCrfZvL1OZxZJMsjYQSNsqwdFlTjdQ5lVqfOmF7R27ti08H6cEUvG__hWn4IboDN2cZfr12Bj4-sn8ZuR7XZOaxo_x8JGQ_cyq9-fWaO0oqH3BIPkYeJVnMA62QC-Ppqt7cjP5BmDcBq99xBo_hsO1rE2jyfW1Sl2vmxy0axwd-zBOYC0iUrTeq8xSmsHoGM9vhrv05_Po2PK5cIBGNPWtiuy6Q6evpZCPLsCKvdnSJp0PN3JEu8_zFYT1ltOuiS47HhhVLuGKBxPW8Ea1G1Z-fv3WTo3domNU1iZ64QBEW7o3mYX_wYW9jKwopGyLDXbyUiXkp0WiCYZniKMh_zJSWyJUo01hazsscCcRgYlQikLBarEttkpzcWORW8RcwTa3jIjArYlEiVUk5obxU6FTQq_vICaQckW334F07d4UJfOYurcZJ0fo1NKiFH9QevO1Exw2Jx_-EVloFKIIdnxeEfwn_iFhRc2-6YrJAd62iKxxNSCbLRU4ro5Q9WGgUp2uFNn_pVkXqrJ_-u5sv1nf3_MPS_UVfw8zu5qD48nHn8zLMJg5w-EDiFZiuzyb4kuBSXb7yZnEFrm0QeQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+positive+association+of+endotoxemia+with+histological+severity+in+237+patients+with+non%E2%80%90alcoholic+fatty+liver+disease&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Pang%2C+J&rft.au=W+Xu&rft.au=Zhang%2C+X&rft.au=G+L%E2%80%90H+Wong&rft.date=2017-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=46&rft.issue=2&rft.spage=175&rft.epage=182&rft_id=info:doi/10.1111%2Fapt.14119&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon |